- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04188808
Prospective Case-control Study in Patients With PAA
A Prospective Case-control Study of the Quality of Life in Patients With Aneurysmatic or Occlusive Disease in the Lower Limb
Study Overview
Status
Intervention / Treatment
Detailed Description
An aneurysm is most commonly defined as a permanent focal dilatation of an artery to 1.5 times its normal diameter. While the abdominal aorta is the most common site of aneurysm formation, the popliteal artery (PA) represents the second most common site of aneurysm formation, accounting for more than 70 percent of all peripheral aneurysms. A popliteal artery aneurysm (PAA) is a focal dilatation of the popliteal artery (red arrow). PAAs are rare in the general population but more commonly found in patient populations with other aneurysms, such as abdominal aortic aneurysm (AAA). Within the general population, PAAs are predominantly found in men and are extremely rare in women. There are few studies on the prevalence of PAAs in healthy individuals, but 14-19% of male and 12% of female AAA patients have PAAs. There is no clear correlation between the diameter of the AAA and the prevalence of PAA. There is furthermore a lack of consensus of the precise arterial diameter that defines a PAA.
It is paramount to identify and treat PAA patients before acute symptoms develop, given the high risk of major complications associated with acute presentation, such as major amputation. Unfortunately, there is a lack of knowledge of the natural history for PAAs, which is why surgical procedures are recommended mainly based on clinical experience and guidelines developed from insufficient scientific information. The preventive purpose, more specifically to prevent the risk of acute symptom development, should be evaluated against the frequency of complications inflicted by surgical treatment, so called "surgical risk". For this reason, it is important to evaluate the patients' health-related quality of life (HRQoL) before and after treatment in order to determine how the surgical treatment affect patients. In general, the Health-Related Quality of Life (HRQoL) is therefore emerging as an important outcome measure for interventions designed to improve patient's health, well-being, or both. There is very limited prior knowledge of HRQoL outcomes following surgical treatment of PAAs and the PAA patient's HRQoL, and whether-and to what extent- it becomes affected by the surgical treatment, is yet unknown. The surgical treatment in PAA patients and patients with peripheral arterial disease (PAD), are comparable whereas the underlying pathologies are distinct. Thus, peripheral arterial disease patients commonly experience substantial symptom relief following a surgical intervention (i.e. lower limb pain is alleviated, or ischemic wound healing is promoted). By contrast, PAA patients are often asymptomatic prior to surgery. It is therefore conceivable that a surgical intervention in PAA patients translates to a lower HRQoL after surgery than what is observed following bypass surgery for PAD. However, this needs to be further explored and confirmed in prospective studies.
Aim To investigate whether the QoL of PAA patients compared to PAD patients after surgical and potential changes over time.
Hypothesis Compared to PAD patients, femoropopliteal/femorodistal bypass surgery interventions undertaken on PAA patients result in a more pronounced negative HRQoL impact.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rebecka Hultgren, Prof
- Phone Number: +46851776596
- Email: rebecka.hultgren@ki.se
Study Contact Backup
- Name: Iva Jergovic, MD
- Phone Number: +46851770947
- Email: iva.jergovic@sll.se
Study Locations
-
-
-
Gothenburg, Sweden
- Recruiting
- Sahlgrenska University Hospital
-
Contact:
- Joakim Nordanstig, MD, assoc prof.
-
Stockholm, Sweden
- Recruiting
- Karolinska University Hospital
-
Contact:
- Iva Jergovic, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients scheduled for elective surgery of PAA (asymptomatic)
- All patients scheduled for elective surgery of PAD
- Elective open surgery
- Intermittent claudication
- Resting pain or very limited minor tissue loss
Exclusion Criteria:
- Cognitive failure
- Major tissue loss
- severe pain
- if one cannot assimilate information in Swedish and understand the questionnaires
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Popliteal artery aneurysm
Asymptomatic popliteal artery aneurysm patients will undergo surgery with a femoropopliteal/femorodistal bypass
|
All patients scheduled for elective surgery of PAA and PAD.
|
Active Comparator: Peripheral artery disease
Patients with peripheral artery disease defined as (ankle - brachial index, ABI <0.5 or typical symptoms); intermittent claudication (IC), or resting pain and/or minor tissue loss.
Will undergo surgery with a femoropopliteal/femorodistal bypass
|
All patients scheduled for elective surgery of PAA and PAD.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SF-36
Time Frame: Five years
|
A 36-item questionnaire that measures 8 dimensions of physical and mental health.
( 0-100) Positive if high
|
Five years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
EQ-5D
Time Frame: Five years
|
EQ-5D is a standardized instrument for measuring generic health status (0-100) 100 best Health and 0 worst helath
|
Five years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PHQ-9 PHQ-9
Time Frame: Five years
|
Depressive symptoms were assessed with the validated nine-item.
Patient Health Questionnaire.
The PHQ provides a dichotomous measure of depressive symptoms ( 0- 30; below 4 = no deression; 10 or above = depression)
|
Five years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Rebecka Hultgren, Prof, Karolinska Instutet
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NPAA0831365
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaRecruitingImprove Quality of LifeItaly
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
Clinical Trials on Bypass surgery
-
University of California, IrvineCompletedMorbid ObesityUnited States
-
Medtronic ItaliaCompletedCoronary Artery DiseaseSwitzerland, Italy
-
Maritime Heart CentreCompletedIschemic Heart DiseaseCanada
-
University of OuluKarolinska Institutet; Universita di Verona; University of Campania "Luigi Vanvitelli... and other collaboratorsRecruitingMyocardial Infarction | Coronary Artery Disease | Angina PectorisFinland
-
National Heart Centre SingaporeDuke-NUS Graduate Medical SchoolUnknownIschemic Heart DiseaseSingapore
-
Wake Forest University Health SciencesCompletedPain, Postoperative | SurgeryUnited States
-
University Hospitals Cleveland Medical CenterElizabeth Severance Prentiss FoundationCompletedObesity | OsteoarthritisUnited States
-
Rockefeller UniversityNew York Obesity and Nutrition Research CenterTerminatedObesity | Weight Loss | Morbid ObesityUnited States
-
Medical University of ViennaTerminatedCoronary Artery DiseaseGermany, Austria, Czech Republic, Norway, Poland, Spain, Sweden
-
Centre Hospitalier Universitaire VaudoisCompletedObesity | Blood Pressure | Bariatric SurgerySwitzerland